CAU
DNLI icon

Caxton Associates (UK)’s Denali Therapeutics DNLI Stock Holding History

Caxton Associates (UK)’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$199K Buy
+14,229
New +$199K 0.01% 630